As TXNDC12 has been implicated in regulating tumor aggressiveness, we next investigated whether its depletion would potentiate the inhibitory effects of cisplatin in HNSCC cells. The gene discussed is TXNDC12; the disease is head and neck squamous cell carcinoma.